Your search did not match any results.
We suggest you try the following to help find what you’re looking for:
Oracle is helping government agencies and the medical community better understand and combat the coronavirus.
Working closely with the NIAID, we’ve developed a cloud service to help identify and screen people who want to participate in COVID-19 vaccine trials. The service will support hundreds of clinical trial sites across the U.S.
Visit the NIAID’s COVID-19 Prevention Network website to learn more about the stages of vaccine research. Share the information on your social networks and sign up for the volunteer registry.
Join us to help reach the goal to register over a million volunteers!
Oracle has built and donated to the US government a COVID-19 Therapeutic Learning System that allows physicians and patients to monitor the effectiveness of promising COVID-19 drug therapies. By collecting this real-world patient data, we can quickly discover which new treatments are most effective against COVID-19. This system is currently available to every physician in the United States at covid19.oracle.com.View the press release View the Q&A
Working with the U.S. Department of Health and Human Services, along with health systems such as Wake Forest Baptist Health and Javara Research, Oracle extended the Therapeutic Learning System to include patient monitoring. These systems can help the medical community better understand the pandemic’s regional infection patterns to develop strategies and treatments to contain and possibly eliminate this novel coronavirus.View the Q&A
Now more than ever, it’s critical that we make it possible for our customers and partners to continue their operations, drive business forward, and help respond to the unique demands that businesses may be facing during this pandemic. For decades, Oracle has been committed to the mission-critical work that keeps businesses and organizations around the world up and running across every industry. We aren’t stopping now.
Count on us to support businesses large and small during the most challenging times and beyond.Learn more